📰 4 sources covering this story

Eli Lilly easily tops quarterly estimates, raises outlook as Zepbound and Mounjaro sales surge

First covered 4 hrs ago · latest take 51 mins ago. Compare how each outlet is covering it — and rate the sources you trust.

Eli Lilly easily tops quarterly estimates, raises outlook as Zepbound and Mounjaro sales surge
CNBC
CNBC51 mins ago
Eli Lilly easily tops quarterly estimates, raises outlook as Zepbound and Mounjaro sales surge
Eli Lilly now expects 2026 revenue to come in between $85 billion and $87 billion, up from a previous guidance of $82 billion and $85 billion.
The Independent
The Independent🏁 first to report4 hrs ago
Next lifts profit outlook again after overseas and summer sales surge
The fashion and homeware retailer lifted its profit outlook again as a result of the stronger-than-expected second quarter.
Next lifts profit outlook again after overseas and summer sales surge
The fashion and homeware retailer lifted its profit outlook again as a result of the stronger-than-expected second quarter.
Top rated outlets
Outlets are ranked once they have 3+ community ratings — be one of the first to rate.
🏆 Most trusted sources 2026 →
Scores come entirely from reader ratings — rate the sources you read to shape them. How it works →